The toxins from the venoms of Elapid snakes have been extensively studied during the past few years and several of them are currently used to label pharmacological receptors and other membrane bound proteins [ 1,2] . On the basis of their structure and of their pharmacological action, Lee [ 1,3] has distinguished in these venoms the cardiotoxins, which, like the y-toxin, the direct lytic factor or cobramine B, produce cardiovascular alterations responsible for local necrotic lesions [4] , and the neurotoxins which block synaptic transmission. The neurotoxins themselves can be subdivided into two main categories : 1) the a-neurotoxin, such as a-bungarotoxin, naja toxin or cobrotoxin are basic polypeptides of 60&62 or 70-74 amino acids, which block synaptic transmission at the neuromuscular junction like curare [5] and bind with a high affinity to the nicotinic receptor site [2,5] and, 2) the fl-neurotoxins, such as P-bungarotoxin and some phospholipases A have a presynaptic action and block the release of acetylcholine [ 1,6,7]. In this letter, we describe the purification and some of the structural and pharmacological properties of a toxin which does not fall into any of these categories. This toxin, that we shall refer to as ceruleotoxin, is present in the venom of the snake Bungarus caemleus. It is an acidic protein which blocks the depolarisation of Electrophoms electroplaque by cholinergic agonists, even though it does not significantly bind to the nicotinic receptor site. 2. Materials and methods